3-mercaptopropionic acid has been researched along with fg 9041 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carcache, D; Kalkman, HO; Koller, M; Mattes, H | 1 |
| Dvorzhak, A; Kirischuk, S; Kirmse, K; Myakhar, O; Unichenko, P | 1 |
2 other study(ies) available for 3-mercaptopropionic acid and fg 9041
| Article | Year |
|---|---|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA | 2010 |
Estimation of ambient GABA levels in layer I of the mouse neonatal cortex in brain slices.
Topics: 3-Mercaptopropionic Acid; Animals; Anisoles; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neocortex; Nipecotic Acids; Oximes; Patch-Clamp Techniques; Quinoxalines; Receptors, GABA-B | 2010 |